3.900USD+5.41%Mkt Cap: 30.63M $P/E: —1d ago
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that r…
Indicators:|
Key Statistics
Company
Market Cap30.63M $
Enterprise Value20.77M $
Revenue (TTM)—
Gross Profit0 $
Net Income (TTM)-11.63M $
Revenue/Share—
Last Price3.900 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryUS
SectorTechnology
IndustryComputer Hardware
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.49
EPS (TTM)-8.49
EPS (Forward)—
52W Range
2.5009% of range17.40
52W High17.40 USD
52W Low2.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.45%
ROA-28.24%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.07M $
CapEx (TTM)2.01M $
FCF Margin—
FCF Yield-21.36%
Net Debt-12.97M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio3.71
Quick Ratio3.52
Book Value/Sh2.620 USD
Cash/Share1.652 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateSep 2, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.85M
Float7.78M
Insiders7.85%
Institutions7.99%
Short Interest
Short Ratio3.5d
Short % Float109.78%
Short % Out.20.33%
Shares Short1.60M
Short (prev mo.)1.74M
Technical
SMA 503.925 (-0.6%)
SMA 2004.061 (-4.0%)
Beta2.14
S&P 52W Chg20.05%
Avg Vol (30d)359.24K
Avg Vol (10d)274.60K
Technical Indicators
RSI (14)50.7
MACD-0.0499
MACD Signal-0.0365
MACD Hist.-0.0134
BB Upper4.085 USD
BB Middle3.837 USD
BB Lower3.588 USD
BB Width12.94%
ATR (14)0.3131 USD
Vol Ratio (20d)0.98x